Skip to main content
. Author manuscript; available in PMC: 2024 Feb 28.
Published in final edited form as: Ann Surg Oncol. 2022 Mar 5;29(6):3810–3819. doi: 10.1245/s10434-022-11367-w

TABLE 3.

Effect of stromal TILs on pCR (ypT0/Tis, N0) in triple negative subtype

Percent stromal TILs Entire cohort ≤ 40 years 41–60 years ≥ 61 years p
TILs ≤ 40% n (% within age group) 286 (84%) 56 (75%) 163 (83%) 67 (96%) 0.037
pCR 101 (35%) 28 (50%) 53 (33%) 20 (30%)
TILs > 40% n (% within age group) 55 (16%) 19 (25%) 33 (17%) 3 (4%) 0.541
pCR 31 (56%) 12 (63%) 18 (55%) 1 (33%)

pCR pathologic complete response, TILs tumor-infiltrating lymphocytes